Wakasugi S, Kageshita T, Ono T
Department of Dermatology, Kumamoto University School of Medicine, Honjo, Kumamoto 860-8556, Japan.
Br J Dermatol. 2001 Aug;145(2):327-9. doi: 10.1046/j.1365-2133.2001.04326.x.
Metastasis to the oral cavity from cutaneous melanoma is rare: fewer than 30 cases of metastatic melanoma to the palatine tonsil have been reported. Tonsil metastasis is haematogenously disseminated and therefore usually has a poor prognosis. We present a case of metastatic melanoma to the palatine tonsil occurring 6(1/2) years after removal of the primary cutaneous lesion. The patient has remained disease-free for 18 months since the removal of skin and tonsil metastases. Immunohistopathologically, HLA class II and costimulatory factor B7-2 molecules were concomitantly expressed on melanoma cells: we suggest that the patient was therefore able to develop antimelanoma T-cell activation resulting in prevention of further metastasis, and thus a favourable prognosis.